Which therapy is listed as a treatment in hospital parvo management but not typically used outpatient?

Which therapy is listed as a treatment in hospital parvo management but not typically used outpatient?

• A. Interferon omega
• B. Cefovecin
• C. Maropitant
• D. IV fluids

Answer: (A)

Interferon omega is an immunomodulatory therapy that is typically reserved for hospital management of canine parvovirus infection. It aims to boost the dog's immune response to the virus, but it is not practical for outpatients due to cost, the need for controlled administration, and limited evidence of clear benefit when used at home. In contrast, therapies like maropitant (antiemetic) are commonly used both in hospital and at home, cefovecin (a long-acting antibiotic) is often used in outpatient care for ease of administration, and IV fluids require hospital-equivalent monitoring and access to IV lines, making home IV therapy uncommon. Therefore, interferon omega stands out as the treatment listed for hospital-based parvo management but not typically used in outpatient care.

Interferon omega is an immunomodulatory therapy that is typically reserved for hospital management of canine parvovirus infection. It aims to boost the dog's immune response to the virus, but it is not practical for outpatients due to cost, the need for controlled administration, and limited evidence of clear benefit when used at home. In contrast, therapies like maropitant (antiemetic) are commonly used both in hospital and at home, cefovecin (a long-acting antibiotic) is often used in outpatient care for ease of administration, and IV fluids require hospital-equivalent monitoring and access to IV lines, making home IV therapy uncommon. Therefore, interferon omega stands out as the treatment listed for hospital-based parvo management but not typically used in outpatient care.